Prognostic Utility of Secretory Phospholipase A2 in Patients With Stable Coronary Artery Disease

Study Questions:

Does secretory phospholipase A2 (sPLA2) have independent prognostic information above established risk markers in patients with stable coronary artery disease (CAD)?